33. ASSESSMENT CONCENTRATION OF D-DIMER AND SOME RELATED FACTORS IN PATIENTS RECOVERED FROM COVID-19 DISEASE
Main Article Content
Abstract
Objective: Describe D-dimer concentrations and analyze factors related to hypercoagulability in post-Covid-19 patients at Dai Phuoc General Clinic.
Subject and method: Retrospectively performed records of 457 patients who had been infected with Covid-19 and had results of quantification of D-dimer concentrations at Dai Phuoc General Clinic from June to July 2022.
Results: 371/457 subjects (81.2%) had D-dimer concentrations < 500 ng/mL and 86/457 subjects had D-dimer concentrations ≥ 500 ng/mL (18.8%). The women have higher D-dimer concentrations than men (z = 5.037, p (sig. (2-sided test)) < 0.05). Patients ≥ 60 years old had higher D-dimer concentrations than those under 60 years old (z = 7,243, p (sig (2-sided test)) < 0.05). Patients with medical conditions were also reported to have higher D-dimer levels than patients without medical conditions (z = 2,999, p (sig (2-sided test)) < 0.05).
Conclusion: Although they have recovered from Covid-19, there is still a fairly high proportion of survey subjects with D-dimer levels higher than the normal threshold, posing a potential risk of hemostatic disorders in post Covid-19 patients. In addition, the study also showed that the group of subjects with abnormal D-dimer concentrations was related to factors such as female gender, age ≥ 60 and comorbidities. Therefore, it is necessary to periodically monitor and screen post Covid-19 people, especially in high-risk groups.
Article Details
Keywords
Post-Covid-19 patients, D-dimer concentrations, hypercoagulability.
References
Hypercoagulability in COVID-19, American
Journal of Cardiovascular Drugs, 20(5), 2020,
pp. 393-403.
[2] Saurabh M, Miriam M, Pathological sequelae of
long-haul COVID, Nature Immunology, 23(2),
2022, pp. 194-202.
[3] Liam T, Helen F et al., Prolonged elevation
of D-dimer levels in convalescent COVID-19
patients is independent of the acute phase
response, Journal of thrombosis and heamostasis,
19(4), 2021.
[4] Swapna M et al., ‘Long-COVID’: a cross
sectional study of persisting symptoms,
biomarker and imaging abnormalities following
hospitalisation for COVID-19, BMJ Journals
76(4), 2021.
[5] Kazuomi K, Takefumi M, Hiroko K, Which
factors affect high D-dimer levels in the elderly?,
Thrombosis Research, 62(5), 1991, pp. 501-508.
[6] Amanda J. Lee et al., Determinants of Fibrin
d-Dimer in the Edinburgh Artery Study,
Arteriosclerosis, Thrombosis, and Vascular
Biology, 8(15), 1995, pp. 1094–1097.
[7] Armando T, D-Dimer Testing in Laboratory
Practice, Clinical Chemistry, 57(9), 2011, pp.
1256-1262.
[8] Evangelos G et al., How to use D-dimer in
acute cardiovascular care, European Heart
Journal Acute Cardiovascular Care, 6(1),
2017, pp. 69-80.